Frequency News and Research

RSS

BioSante reports positive results from Phase II study of Pill-Plus "triple hormone" oral contraceptive

BioSante Pharmaceuticals, Inc. announced today positive results in a Phase II study of the Pill-Plus "triple hormone" oral contraceptive (OC). Results showed an increase in the frequency of sexual activity (p< 0.05) and reduced frequency of rejection of initiation of sexual activity by partner (p< 0.05).

30 Jun 2010

Infection and severe sepsis mortality rates higher in black patients

A greater frequency of severe sepsis among black patients is attributable to higher rates of infection and higher risks of organ dysfunction than what white patients experience, according to a study in the June 23/30 issue of JAMA.

30 Jun 2010

Vimpat provides long-term additional partial-onset seizure control when added to broad range of AEDs

New long term data showed that Vimpat- (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy. In addition post-hoc exploratory analyses showed that adjunctive lacosamide treatment reduced partial-onset seizure frequency and improved responder rates when added to a broad range of antiepileptic drugs (AEDs) including both traditional sodium channel-blocking agents and those that act on non-sodium channel-targets.

30 Jun 2010

Wishard-Regenstrief partnership earns NAPH President's Award for Health Reform Readiness and Leadership

Wishard Health Services, the nation's third-largest safety net health care system in outpatient visits, and the Regenstrief Institute Inc., an internationally-respected medical and public health informatics innovator, earned the NAPH 2010 President's Award for Health Reform Readiness and Leadership.

30 Jun 2010

New strategies can improve continuity of primary care, shorten patient waiting time

A national shortage of primary care doctors plus a growing population of older adults, many with chronic diseases, is leading in some underserved areas to longer wait times to see a doctor and is reducing patients' chances of seeing their own physician, experts say.

30 Jun 2010

Routine testing of inmates can reduce HIV incidence in the U.S.

Routine, jail-based HIV testing of inmates can successfully identify a substantial proportion of people unknowingly infected with HIV and could play a critical role in preventing the spread of the disease, according to a new report in this week's U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

29 Jun 2010

Health Canada recommends new pneumococcal vaccine for young children

In December, 2009, Health Canada approved a new vaccine for children aged six weeks through five years to prevent infections caused by the bacteria called pneumococcus or Streptococcus.

29 Jun 2010

A&A journal achieves significant increase in Impact Factor; reflects scientific value of medical journals

Anesthesia & Analgesia (A&A), official journal of the International Anesthesia Research Society (IARS), has achieved a significant increase in its Impact Factor, a key indicator of the influence and scientific value of medical journals, the IARS announced today.

29 Jun 2010

FDA's acceptance for filing of DM-1796 NDA triggers $10M milestone payment to Depomed

Depomed, Inc. today announced that it has received a $10 million milestone payment from Abbott Products, Inc., its licensee of DM-1796, for the U.S. Food and Drug Administration's acceptance for filing of the New Drug Application (NDA) for DM-1796 for the management of postherpetic neuralgia (PHN), or pain after shingles.

29 Jun 2010

UB study: Vietnam veterans exposed to Agent Orange are more likely to develop Graves' disease

Vietnam War-era veterans exposed to Agent Orange appear to have significantly more Graves' disease, a thyroid disorder, than veterans with no exposure, a new study by endocrinologists at the University at Buffalo has shown.

29 Jun 2010

Lead researchers develop a novel technique to deliver cancer drugs

A new way to deliver cancer drugs using gas bubbles and sound waves is to be developed at the University of Leeds. The project will enable highly toxic drugs to be delivered in small doses directly to tumours, where their toxicity can safely be put to good use.

29 Jun 2010

A neuro-optometric rehabilitation case report

The College of Optometrists in Vision Development (COVD) has posted its current issue of Optometry & Vision Development online and invites all to read the full-text articles free of charge.

29 Jun 2010

Increased follow-up care proves key to helping depressed patients feel better

New data released by two non-profit health care organizations, MN Community Measurement and the Institute for Clinical Systems Improvement, indicate that Minnesota providers only slightly improved their quality of care for patients with depression from a year ago, but that new programs that increase clinic contact with the patient demonstrate the potential for much better results moving forward.

28 Jun 2010

Raptor initiates enrollment in pivotal Phase 3 clinical trial of DR Cysteamine for nephropathic cystinosis

Raptor Pharmaceutical Corp. announced that it has enrolled the first patient in a pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

28 Jun 2010

Lantus and Apidra injections improve glycemic control, reduce hospital complications: Study

Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals improved glycemic control and reduced hospital complications, compared to "sliding scale" insulin in general surgery patients with type 2 diabetes.

28 Jun 2010

Genomic analysis leads to more effective diagnostic tests, treatment options for prostate cancer: Study

A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. "Genomic studies in other cancer types have resulted in new drug targets and strategies to classify patients into clinically meaningful subgroups that improve treatment decisions," said senior study author Charles Sawyers, Chair of the Human Oncology and Pathogenesis Program at MSKCC and a HHMI investigator. "This first -ever database of its type brings us one step closer to achieving that goal in prostate cancer."

28 Jun 2010

St. Luke's joins Dr. John Goss in celebration of his 1,000th liver transplantation procedure

St. Luke's Episcopal Hospital (St. Luke's) joins John Goss, M.D., in celebrating his milestone as he recently performed his 1,000th liver transplantation procedure. The largest liver transplant program in Houston's world-renowned Texas Medical Center, St. Luke's performs approximately 75 liver transplants annually. Additionally, St. Luke's liver transplant survival rate is the highest in the nation, with a one-year adult patient survival rate of 96.5 percent compared to the national expected survival rate of 89.38 percent.

24 Jun 2010

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

The Accreditation Council for Graduate Medical Education task force charged with reassessing resident training program standards today presented a comprehensive set of draft standards that revise requirements for supervision and duty hours to better match residents' levels of experience and emerging competencies, advancing both graduate medical education and quality patient care in the nation's teaching hospitals.

24 Jun 2010

RF Technologies completes installation of Safe Place Infant and Pediatric Security Solution for Baptist Memorial

RF Technologies®, a leading provider of radio frequency identification monitoring systems and healthcare security solutions, announces it has completed installation of its Safe Place® Infant and Pediatric Security Solution for Baptist Memorial Health Care. The health care system, serving locations throughout the Mid-South, delivers approximately 10,000 babies a year at eight affiliate hospitals that provide obstetric care.

24 Jun 2010

Treatment options for patients with MS

The best one-word description for multiple sclerosis is "unpredictable," according to the June issue of Mayo Clinic Women's HealthSource. MS interferes with the communication between the brain and the rest of the body. Just how that interference plays out in symptoms is different for everyone -- thus, the unpredictable label.

24 Jun 2010

Frequency News and Research

BioSante reports positive results from Phase II study of Pill-Plus "triple hormone" oral contraceptive

Infection and severe sepsis mortality rates higher in black patients

Vimpat provides long-term additional partial-onset seizure control when added to broad range of AEDs

Wishard-Regenstrief partnership earns NAPH President's Award for Health Reform Readiness and Leadership

New strategies can improve continuity of primary care, shorten patient waiting time

Routine testing of inmates can reduce HIV incidence in the U.S.

Health Canada recommends new pneumococcal vaccine for young children

A&A journal achieves significant increase in Impact Factor; reflects scientific value of medical journals

FDA's acceptance for filing of DM-1796 NDA triggers $10M milestone payment to Depomed

UB study: Vietnam veterans exposed to Agent Orange are more likely to develop Graves' disease

Lead researchers develop a novel technique to deliver cancer drugs

A neuro-optometric rehabilitation case report

Increased follow-up care proves key to helping depressed patients feel better

Raptor initiates enrollment in pivotal Phase 3 clinical trial of DR Cysteamine for nephropathic cystinosis

Lantus and Apidra injections improve glycemic control, reduce hospital complications: Study

Genomic analysis leads to more effective diagnostic tests, treatment options for prostate cancer: Study

St. Luke's joins Dr. John Goss in celebration of his 1,000th liver transplantation procedure

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

RF Technologies completes installation of Safe Place Infant and Pediatric Security Solution for Baptist Memorial

Treatment options for patients with MS

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News